MiR‐548 K regulatory effect on the ABCG2 gene expression in MDR breast cancer cells
Authors:
Open Access
- 11 May 2023
- journal article
- research article
- Published by Wiley in Cancer Reports
- Vol. 6 (6) , e1816
Abstract
Background: multidrug resistance (MDR) is One of the foremost challenges in overcoming breast cancer. Various molecular processes are involved in the development of MDR in breast cancer cells, including over expression of ABC transporters such as ABCG2 (BCRP), increase breast cancer stem cells drug resistance, and epithelial mesenchymal transition.Aims: In the present study, we used bioinformatics and experimental analysis to investigate the role of miR‐548 K, in the modulating of ABCG2, in MDR breast cancer cells.Methods and Results: In silico inspections introduce 14 microRNAs targeting 3′‐UTR region of ABCG2 transcripts, which are probably involved in breast cancer drug resistance. An association was highlighted between miR‐548 k with ABC transporter family. The expression level of ABCG2 gene in MCF7‐MX cell lines was significantly more than MCF7 cell lines. On the other hand, we increased the expression of miR‐548 K in MCF7‐MX and MCF7 cell lines through its transfection, which dramatically coincided with decreasion in the ABCG2 transcripts level. Additional studies on patient samples revealed that the expression of ABCG2 showed an increase in ABCG2 level in neoadjuvant chemotherapy drugs resistance (NCDR) patients compared to primary pre‐operative chemotherapy drugs response (PCDR) patients. Also, a reduction in the expression of miR‐548 K in NCDR patients was revealed.Conclusion: The results of our study suggest that miR‐548 K may be involved in modulating the expression of ABCG2 in MDR breast cancer cells.Keywords
Funding Information
- Shahrekord University of Medical Sciences (3417, 3529)
This publication has 22 references indexed in Scilit:
- Up-regulated miR-548k promotes esophageal squamous cell carcinoma progression via targeting long noncoding RNA-LETExperimental Cell Research, 2018
- miR-155 in cancer drug resistance and as target for miRNA-based therapeuticsCancer and Metastasis Reviews, 2017
- Overcoming ABC transporter-mediated multidrug resistance: Molecular mechanisms and novel therapeutic drug strategiesDrug Resistance Updates, 2016
- MiR-548-3p functions as an anti-oncogenic regulator in breast cancerBiomedicine & Pharmacotherapy, 2015
- MicroRNA–mRNA interactions in colorectal cancer and their role in tumor progressionGenes, Chromosomes and Cancer, 2015
- Breast cancer resistance protein (BCRP/ABCG2): its role in multidrug resistance and regulation of its gene expressionChinese Journal of Cancer, 2012
- ABCG2 is associated with HER-2 Expression, lymph node metastasis and clinical stage in breast invasive ductal carcinomaDiagnostic Pathology, 2011
- Breast cancer resistance protein BCRP/ABCG2 regulatory microRNAs (hsa-miR-328, -519c and -520h) and their differential expression in stem-like ABCG2+ cancer cellsBiochemical Pharmacology, 2011
- Expression of Plakophilins (PKP1, PKP2, and PKP3) in Gastric CancersDiagnostic Pathology, 2011
- MicroRNA-328 Negatively Regulates the Expression of Breast Cancer Resistance Protein (BCRP/ABCG2) in Human Cancer CellsMolecular Pharmacology, 2009